Announcements Trials
Browse Landscape

Phase

Phase 2/3 1

Status

Completed 7Terminated 6Unknown 1Recruiting 1Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Neoplasms 2Fatigue 1Depression 1Brain Neoplasms 1Anxiety Disorders 1

Interventions

Exercise 3Cognitive Behavioral Therapy 3Educational Status 2enzalutamide 1darolutamide 1apalutamide 1Testosterone 1Surveys and Questionnaires 1Surgical Procedures, Operative 1Saline Solution 1Radiotherapy 1Quality of Life 1Palliative Care 1Neuropsychological Tests 1Muscle Stretching Exercises 1Modafinil 1Methylphenidate 1Methods 1Mental Status and Dementia Tests 1Melatonin 1Laughter Therapy 1Gels 1Control Groups 1Consolidation Chemotherapy 1Chemoradiotherapy 1Caregivers 1Acupuncture, Ear 1Acupressure 1Acceptance and Commitment Therapy 1Abiraterone Acetate 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Recruiting × Fatigue × Methylphenidate × Clear all
NCT05474846 2025-11-06

Combination Therapy for Treatment of Sleep Disturbance in Patients With Advanced Cancer

M.D. Anderson Cancer Center

Phase 2/3 Recruiting
188 enrolled

Anxiety Disorders, Depression, Fatigue, Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡